5 active trials 1 recruiting 1 Phase 3 9 disease areas 4 changes in 30 days
| Phase 1 | 3 | |
| Phase 2 | 1 | |
| Phase 3 | 1 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 3 | ||||
| NCT07766421 | Evaluation of Iopofosine I 131 vs. R-CD in WM Patients | Waldenstrom Macroglobulinaemia | Not Yet Recruiting | 2026-08-14 |
| Phase 2 | ||||
| NCT02952508 | Study of Iopofosine I-131 (CLR 131) in Select B-Cell Malignancies (CLOVER-1) With… | Waldenstrom Macroglobulinemia | Active, Not Recruiting | 2026-03-18 |
| Phase 1 | ||||
| NCT07311993 | Phase 1 Study of CLR 125 in Triple Negative Breast Cancer | Breast Cancer | Recruiting | 2026-06-03 |
| NCT03478462 | Dose Escalation Study of CLR 131 in Pediatric Relapsed/Refractory Malignant Tumors… | Pediatric Solid Tumor | Active, Not Recruiting | 2026-10-01 |
| NCT05610891 | Novel Targeted Radiotherapy in Pediatric Patients With Inoperable Relapsed or Refractory… | High-Grade Glioma | Active, Not Recruiting | 2026-10-01 |
Breast Cancer (1) · Chronic Lymphocytic Leukemia (CLL) (1) · DLBCL (1) · Glioma (1) · Leukemia (1) · Mantle Cell Lymphoma (1) · Multiple Myeloma (1) · Non-Hodgkin Lymphoma (1) · Sarcoma (1)